Cited by 845Cancer Mechanisms and TherapyProtein Kinase Regulation and GTPase SignalingMechanisms of cancer metastasis

The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.

Src family kinases in tumor progression and metastasis

Summy, Justin M., Gallick, Gary E.·2003·Cancer and Metastasis Reviews

Open this paper in CoChat — free account

Abstract

The Src family of non-receptor protein tyrosine kinases plays critical roles in a variety of cellular signal transduction pathways, regulating such diverse processes as cell division, motility, adhesion, angiogenesis, and survival. Constitutively activated variants of Src family kinases, including the viral oncoproteins v-Src and v-Yes, are capable of inducing malignant transformation of a variety of cell types. Src family kinases, most notably although not exclusively c-Src, are frequently overexpressed and/or aberrantly activated in a variety of epithelial and non-epithelial cancers. Activation is very common in colorectal and breast cancers, and somewhat less frequent in melanomas, ovarian cancer, gastric cancer, head and neck cancers, pancreatic cancer, lung cancer, brain cancers, and blood cancers. Further, the extent of increased Src family activity often correlates with malignant potential and patient survival. Activation of Src family kinases in human cancers may occur through a variety of mechanisms and is frequently a critical event in tumor progression. Exactly how Src family kinases contribute to individual tumors remains to be defined completely, however they appear to be important for multiple aspects of tumor progression, including proliferation, disruption of cell/cell contacts, migration, invasiveness, resistance to apoptosis, and angiogenesis. This review details the evidence for Src family activation in human tumors, and emphasizes possible consequences to tumor progression. Given the ability of Src and its family members to participate in so many aspects of tumor progression and metastasis, Src family kinases are attractive targets for future anti-cancer therapeutics.

Integrity signals

Registry

Crossref · 10.1023/a:1023772912750

Cites

171 of 171 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
Thomas, S. Μ., & Brugge, J. S. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.513 · Cited by 2,537
Transforming gene product of Rous sarcoma virus phosphorylates tyrosine
Hunter, T. R., & Sefton, B. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1311 · Cited by 2,333
Three-dimensional structure of the tyrosine kinase c-Src
Xu, W., Harrison, S. C., & Eck, M. J. (1997) · Nature · doi:10.1038/385595a0 · Cited by 1,432
DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA
STEHELIN, D., VARMUS, H. E., BISHOP, J. M., & VOGT, P. K. (1976) · Nature · doi:10.1038/260170a0 · Cited by 1,321 · cited 2×
“Through then very tedious molecular approaches, Bishop and Varmus [3] demonstrated that the viral Src gene (v-src) had as its progenitor a normal cellular gene (proto-oncogene) c-src, an experiment largely responsible for the awarding of the”
Background
Regulation, substrates and functions of src
Brown, M. T., & Cooper, J. A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00003-0 · Cited by 1,193
Crystal structure of the Src family tyrosine kinase Hck
Sicheri, F., Moarefi, I., & Kuriyan, J. (1997) · Nature · doi:10.1038/385602a0 · Cited by 1,171
A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS
Rous, P. (1911) · Journal of Experimental Medicine · doi:10.1084/jem.13.4.397 · Cited by 1,051
Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells.
Migliaccio, A., Domenico, M. D., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 950
Identification of a transformation-specific antigen induced by an avian sarcoma virus
Brugge, J. S., & Erikson, R. L. (1977) · Nature · doi:10.1038/269346a0 · Cited by 889
Role of Src expression and activation in human cancer
Irby, R., & Yeatman, T. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203912 · Cited by 878

Show all 171 references

Items 301–400 of 845

Components in aqueous Hibiscus rosa-sinensis flower extract inhibit in vitro melanoma cell growth
Goldberg, K. H., Yin, A. C., Mupparapu, A., Retzbach, E. P., Goldberg, G. S., & Yang, C. F. (2016) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2016.01.005 · Cited by 41
Dasatinib in solid tumors
Kim, L. C., Rix, U., & Haura, E. B. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543781003592097 · Cited by 41
Curcumin Blocks RON Tyrosine Kinase–Mediated Invasion of Breast Carcinoma Cells
Narasimhan, M., & Ammanamanchi, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6883 · Cited by 40
Combined Inhibition of IGF-1R/IR and Src Family Kinases Enhances Antitumor Effects in Prostate Cancer by Decreasing Activated Survival Pathways
Dayyani, F., Parikh, N. U., Varkaris, A. S., Song, J. H., Moorthy, S., Chatterji, T., Maity, S. N., Wolfe, A. R., Carboni, J. M., Gottardis, M. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051189 · Cited by 40
Self-citation
Bone-targeting agents in prostate cancer
Suzman, D. L., Boikos, S. A., & Carducci, M. A. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9480-2 · Cited by 43
Cooperative expression of junctional adhesion molecule‐C and ‐B supports growth and invasion of glioma
Tenan, M., Aurrand‐Lions, M., Widmer, V., Alimenti, A., Burkhardt, K., Lazeyras, F., Belkouch, M., Hammel, P., Walker, P. R., Duchosal, M. A., et al. (2009) · Glia · doi:10.1002/glia.20941 · Cited by 40
c-Src-dependent cross-talk between CEACAM6 and αvβ3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components
Duxbury, M. S., Ito, H., Ashley, S. W., & Whang, E. E. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.018 · Cited by 40
A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies
Naing, A., Cohen, R. B., Dy, G. K., Hong, D. S., Dyster, L. M., Hangauer, D. G., Kwan, R., Fetterly, G. J., Kurzrock, R., & Adjei, A. A. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-9929-8 · Cited by 40
Antiproliferative Effects of Src Inhibition on Medullary Thyroid Cancer
Liu, Z., Falola, J., Zhu, X., Gu, Y., Kim, L. T., Sarosi, G. A., Anthony, T., & Nwariaku, F. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031917 · Cited by 40
Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling
Bieerkehazhi, S., Chen, Z., Zhao, Y., Yu, Y., Zhang, H., Vasudevan, S. A., Woodfield, S. E., Tao, L., Yi, J. S., Muscal, J. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13643 · Cited by 41
PTP1B expression contributes to gastric cancer progression
Wang, J., Liu, B., Chen, X., Su, L., Wu, P., Wu, J., & Zhu, Z. (2011) · Medical Oncology · doi:10.1007/s12032-011-9911-2 · Cited by 39
Combined Inhibition of PLCγ-1 and c-Src Abrogates Epidermal Growth Factor Receptor–Mediated Head and Neck Squamous Cell Carcinoma Invasion
Nozawa, H., Howell, G. M., Suzuki, S., Zhang, Q. H., Qi, Y., Klein‐Seetharaman, J., Wells, A. H., Grandis, J. R., & Thomas, S. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4857 · Cited by 39
v-Src causes delocalization of Mklp1, Aurora B, and INCENP from the spindle midzone during cytokinesis failure
Soeda, S., Nakayama, Y., Honda, T., Aoki, A., Tamura, N., Abe, K., Fukumoto, Y., & Yamaguchi, N. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.02.023 · Cited by 39
Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells
Ungefroren (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.897 · Cited by 39
Recent developments in treatments targeting castration-resistant prostate cancer bone metastases
Loriot, Y., Massard, C., & Fizazi, K. S. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr573 · Cited by 38
Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study
Isakoff, S. J., Wang, D., Campone, M., Calles, A., Leip, E. P., Turnbull, K. W., Bardy‐Bouxin, N., Duvillié, L., & Calvo, E. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.508 · Cited by 38
Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis
Zhang, X., Su, L., Pirani, A., Wu, H., Zhang, H.-Z., Shin, D. M., Gernert, K., & Chen, Z. (2006) · Clinical and Experimental Metastasis · doi:10.1007/s10585-006-9031-0 · Cited by 35
Focal Adhesion Kinase Functions as an Akt Downstream Target in Migration of Colorectal Cancer Cells
Turečková, J., Vojtěchová, M., Krausová, M., Šloncová, E., & Kořínek, V. (2009) · Translational Oncology · doi:10.1593/tlo.09160 · Cited by 37
Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells
Tawadros, T., Brown, M. D., Hart, C. A., & Clarke, N. W. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.457 · Cited by 38
Migfilin Interacts with Src and Contributes to Cell-Matrix Adhesion-mediated Survival Signaling
Zhao, J., Zhang, Y., Ithychanda, S. S., Tu, Y., Chen, K., Qin, J., & Wu, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045021 · Cited by 37
Roles of Fyn in pancreatic cancer metastasis
Chen, Z., Cai, L., Bie, P., Wang, S., Jiang, Y., Dong, J., & Li, X. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06021.x · Cited by 37
A TRIF-Independent Branch of TLR3 Signaling
Yamashita, M., Chattopadhyay, S., Fensterl, V., Zhang, Y., & Sen, G. C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103220 · Cited by 38
Bosutinib: a dual SRC/ABL kinase inhibitor for the treatment of chronic myeloid leukemia
Keller, G., Schafhausen, P., & Brümmendorf, T. H. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.42 · Cited by 39
Src inhibitors in breast cancer therapy
Hiscox, S., & Nicholson, R. I. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.6.757 · Cited by 36
Clinical Development of Src Tyrosine Kinase Inhibitors in Lung Cancer
Lee, D. L., & Gautschi, O. P. (2006) · Clinical Lung Cancer · doi:10.3816/clc.2006.n.020 · Cited by 37
Increases in c-Yes Expression Level and Activity Promote Motility But Not Proliferation of Human Colorectal Carcinoma Cells
Barraclough, J., Hodgkinson, C. L., Hogg, A., Dive, C., & Welman, A. (2007) · Neoplasia · doi:10.1593/neo.07442 · Cited by 37
Inhibition of c-Src/p38 MAPK pathway ameliorates renal tubular epithelial cells apoptosis in db/db mice
Wu, H., Shi, Y., Deng, X., Su, Y., Du, C., Wei, J., Ren, Y., Wu, M. T., Hou, Y., & Duan, H. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.008 · Cited by 36
Kinase signaling pathways as targets for intervention in pancreatic cancer
Preis, M., & Korc, M. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.10.11534 · Cited by 36
Profile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemia
Koschmieder, S., & Keller-v.Amsberg (2013) · OncoTargets and Therapy · doi:10.2147/ott.s19901 · Cited by 40
The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling
Asbagh, L. A., Vázquez, I., Vecchione, L., Budínská, E., de Vriendt, V., Baietti, M. F., Steklov, M. Y., Jacobs, B., Hoe, N., Singh, S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2458 · Cited by 36
Expression of N-myristoyltransferase in Human Brain Tumors
Lu, Y., Selvakumar, P., Ali, K., Shrivastav, A., Bajaj, G. D., Resch, L., Griebel, R., Fourney, D. R., V, Meguro, K., & Sharma, R. K. (2005) · Neurochemical Research · doi:10.1007/s11064-004-9680-9 · Cited by 36
Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer
Zou, H., Luo, J., Guo, Y., Tong, T., Liu, Y., Chen, Y., Xiao, Y., Ye, L., Zhu, C., Deng, L., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04688-w · Cited by 38
Radiation promotes malignant phenotypes through SRC in breast cancer cells
Kim, R., Cui, Y., Yoo, K.-C., Kim, I., Lee, M., Choi, Y. H., Suh, Y., & Lee, S. (2014) · Cancer Science · doi:10.1111/cas.12574 · Cited by 35
A Phase II Trial of Saracatinib, an Inhibitor of src Kinases, in Previously-Treated Advanced Non–Small-Cell Lung Cancer: The Princess Margaret Hospital Phase II Consortium
Laurie, S. A., Goss, G. D., Shepherd, F. A., Reaume, M. N., Nicholas, G. A., Philip, L., Wang, L. E., Schwock, J., Hirsh, V., Oza, A. M., et al. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.08.001 · Cited by 35
PRRG4 promotes breast cancer metastasis through the recruitment of NEDD4 and downregulation of Robo1
Zhang, L., Qin, Y., Wu, G. J., Wang, J., Cao, J., Wang, Y., Wu, D., Yang, K., Zhao, Z., He, L., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01494-7 · Cited by 35
Emerging applications for phospho-proteomics in cancer molecular therapeutics
Moran, M. F., Tong, J., Taylor, P. P., & Ewing, R. M. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.002 · Cited by 35
A novel Src kinase inhibitor reduces tumour formation in a skin carcinogenesis model
Serrels, B., Serrels, A., Mason, S. M., Baldeschi, C., Ashton, G. H. S., Canel, M., Mackintosh, L. J., Doyle, B. J., Green, T. P., Frame, M. C., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn278 · Cited by 36
The pK a of Brønsted acids controls their reactivity with diazo compounds
Fei, N., Sauter, B., & Gillingham, D. G. (2016) · Chemical Communications · doi:10.1039/c6cc03561b · Cited by 35
Targeting SRC and epidermal growth factor receptor in colorectal cancer: rationale and progress into the clinic.
Kopetz, S. (2007) · PubMed · Cited by 36
Down-regulation of the Tumor Suppressor C-terminal Src Kinase (Csk)-binding Protein (Cbp)/PAG1 Is Mediated by Epigenetic Histone Modifications via the Mitogen-activated Protein Kinase (MAPK)/Phosphatidylinositol 3-Kinase (PI3K) Pathway
Suzuki, K., Oneyama, C., Kimura, H., Tajima, S., & Okada, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.195362 · Cited by 35
Combined SFK/mTOR Inhibition Prevents Rapamycin-Induced Feedback Activation of AKT and Elicits Efficient Tumor Regression
Yori, J. L., Lozada, K. L., Seachrist, D. D., Mosley, J. D., Abdul‐Karim, F. W., Booth, C. N., Flask, C. A., & Keri, R. A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3627 · Cited by 34
Antitumor activity of 7RH, a discoidin domain receptor 1 inhibitor, alone or in combination with dasatinib exhibits antitumor effects in nasopharyngeal carcinoma cells
Lu, Q., Chen, W.-D., Peng, J., Xu, Y., Cai, Q., Feng, G., Ding, K., Zhu, X., & Guan, Z. (2016) · Oncology Letters · doi:10.3892/ol.2016.5088 · Cited by 34
Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis
Roversi, F. M., Pericole, F. V., Machado‐Neto, J. A., Duarte, A. S. S., Longhini, A. L. F., Corrocher, F. A., Palodetto, B., Ferro, K. P., Rosa, R. G., Baratti, M. O., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.013 · Cited by 34
RanBP9/TSSC3 complex cooperates to suppress anoikis resistance and metastasis via inhibiting Src-mediated Akt signaling in osteosarcoma
Dai, H., Lv, Y., Yan, G., Meng, G., Zhang, X., & Guo, Q. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.436 · Cited by 35
lncRNA TPTEP1 competitively sponges miR‑328‑5p to inhibit the proliferation of non‑small cell lung cancer cells
Cao, F., Wang, Z., Feng, Y., Zhu, H., Yang, M., Zhang, S., & Wang, X. (2020) · Oncology Reports · doi:10.3892/or.2020.7522 · Cited by 34
Biosensors based on peptide exposure show single molecule conformations in live cells
Liu, B., Stone, O. J., Pablo, M., Herron, J. C., Nogueira, A. T., Dağliyan, O., Grimm, J. B., Lavis, L. D., Elston, T. C., & Hahn, K. M. (2021) · Cell · doi:10.1016/j.cell.2021.09.026 · Cited by 35
Proteomics: a strategy to understand the novel targets in protein misfolding and cancer therapy
Nagathihalli, N. S., Singh, O. V., & Merchant, N. B. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.70 · Cited by 34
B cell proliferation following CD40 stimulation results in the expression and activation of Src protein tyrosine kinase
Néron, S., Suck, G., Ma, X., Sakac, D., Roy, A., Katsman, Y., Dussault, N., Racine, C., & Branch, D. R. (2006) · International Immunology · doi:10.1093/intimm/dxh377 · Cited by 34
Src Family Kinase Inhibitors Block Amphiregulin-Mediated Autocrine ErbB Signaling in Normal Human Keratinocytes
Kansra, S., Stoll, S. W., Johnson, J. L., & Elder, J. T. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.004689 · Cited by 34
Analysis of SRC Oncogenic Signaling in Colorectal Cancer by Stable Isotope Labeling with Heavy Amino Acids in Mouse Xenografts
Sirvent, A., Vigy, O., Orsetti, B., Urbach, S., & Roche, S. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.018168 · Cited by 33
Therapeutic targeting of tumor–stroma interactions
Hiscox, S., Barrett-Lee, P. J., & Nicholson, R. I. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.561201 · Cited by 34
Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer
Wheeler, S. E., Morariu, E., Bednash, J., Otte, C. G., Seethala, R., Chiosea, S., & Grandis, J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2486 · Cited by 38
Inhibition of SRC family kinases reduces myeloid‐derived suppressor cells in head and neck cancer
Mao, L., Deng, W., Yu, G., Bu, L., Liu, J., Ma, S., Wu, L., Kulkarni, A. B., Zhang, W., & Sun, Z. (2016) · International Journal of Cancer · doi:10.1002/ijc.30493 · Cited by 33
Kinase Inhibitors and Ovarian Cancer
Katopodis, P., Chudasama, D. Y., Wander, G., Sales, L., Kumar, J., Pandhal, M., Anikin, V., Chatterjee, J., Hall, M., & Karteris, E. (2019) · Cancers · doi:10.3390/cancers11091357 · Cited by 33
Tirbanibulina: revisión de su mecanismo de acción novedoso y de cómo encaja en el tratamiento de la queratosis actínica
Gilaberte, Y., & Fernández‐Figueras, M. T. (2021) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2021.07.006 · Cited by 33
Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling
Xiao, J., Xu, M., Hou, T., Huang, Y., Yang, C., & LI, J. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3784 · Cited by 36
Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-Src
Guo, B., Zhang, Y., Hui, Q., Wang, H., & Tao, K. X. (2015) · Tumor Biology · doi:10.1007/s13277-015-4235-z · Cited by 33
Apoptosis-associated tyrosine kinase 1 inhibits growth and migration and promotes apoptosis in melanoma
Ma, S., & Rubin, B. P. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.13 · Cited by 33
Novel N9-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors
Wang, Y., Shakespeare, W. C., Huang, W.-S., Sundaramoorthi, R., Lentini, S. P., Das, S., Liu, S., Banda, G., Wen, D., Zhu, X., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.042 · Cited by 33
Tyrosine kinase signalling in embryonic stem cells
Annerén, C. (2008) · Clinical Science · doi:10.1042/cs20070388 · Cited by 33
Androgen Receptor Activation in Castration-Recurrent Prostate Cancer: The Role of Src-Family and Ack1 Tyrosine Kinases
Gelman, I. H. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.8264 · Cited by 35
Inhibition of Protein N-Myristoylation: A Therapeutic Protocol in Developing Anticancer Agents
Das, U., Kumar, S., Dimmock, J. R., & Sharma, R. K. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912801784857 · Cited by 33
Fibronectin and type IV collagen activate ERα AF-1 by c-Src pathway: effect on breast cancer cell motility
Sisci, D., Aquila, S., Middea, E., Gentile, M., Maggiolini, M., Mastroianni, F., Montanaro, D., & Andò, S. (2004) · Oncogene · doi:10.1038/sj.onc.1208098 · Cited by 34
Small-Molecule Protein Tyrosine Kinase Inhibitors for the Treatment of Metastatic Prostate Cancer
Gallick, G. E., Corn, P. G., Zurita, A. J., & Lin, S.-H. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.161 · Cited by 32
Self-citation
Lyn Facilitates Glioblastoma Cell Survival under Conditions of Nutrient Deprivation by Promoting Autophagy
Liu, W. M., Huang, P., Kar, N. S., Burgett, M. E., Muller-Greven, G. M., Nowacki, A. S., Distelhorst, C., Lathia, J. D., Rich, J. N., Kappes, J. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070804 · Cited by 32
Historical retrospective of the SRC oncogene and new perspectives (Review)
Simatou, A., Simatos, G., Goulielmaki, M., Spandidos, D. A., Baliou, S., & Zoumpourlis, V. (2020) · Molecular and Clinical Oncology · doi:10.3892/mco.2020.2091 · Cited by 34
DDR1 promotes migration and invasion of breast cancer by modulating the Src-FAK signaling
Han, Q., Xiao, F., Ma, L., Zhou, J., Wang, L., Cheng, H., Zhu, J., Yao, F., Lyu, J., & Du, L. (2022) · Neoplasma · doi:10.4149/neo_2022_220316n289 · Cited by 33
BCAR3 Regulates Src/p130Cas Association, Src Kinase Activity, and Breast Cancer Adhesion Signaling*
Schuh, N. R., Guerrero, M. S., Schrecengost, R. S., & Bouton, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.046631 · Cited by 36
Colon cancer cell adhesion in response to Src kinase activation and actin‐cytoskeleton by non‐laminar shear stress
Thamilselvan, V., Patel, A. R., van Zyp, J. R. N. V. D. V., & Basson, M. D. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20072 · Cited by 32
Podoplanin promotes cell migration via the EGF-Src-Cas pathway in oral squamous cell carcinoma cell lines
Inoue, H., Miyazaki, Y., Kikuchi, K., Yoshida, N., Ide, F., Ohmori, Y., Tomomura, A., Sakashita, H., & Kusama, K. (2012) · Journal of Oral Science · doi:10.2334/josnusd.54.241 · Cited by 31
XIAP Interaction with E2F1 and Sp1 via its BIR2 and BIR3 domains specific activated MMP2 to promote bladder cancer invasion
Xu, J., Hua, X., Yang, R., Jin, H., Li, J., Zhu, J., Tian, Z., Huang, M., Jiang, G., Huang, H., et al. (2019) · Oncogenesis · doi:10.1038/s41389-019-0181-8 · Cited by 31
A novel intracellular isoform of VEGFR‐1 activates Src and promotes cell invasion in MDA‐MB‐231 breast cancer cells
Mezquita, B., Mezquita, J., Pau, M., & Mezquita, C. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22584 · Cited by 31
Src-mediated regulation of homotypic cell adhesion: implications for cancer progression and opportunities for therapeutic intervention
Wadhawan, A., Smith, C. R., Nicholson, R. I., Barrett-Lee, P. J., & Hiscox, S. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.08.003 · Cited by 31
Bone Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer
Rajpar, S., & Fizazi, K. S. (2013) · The Cancer Journal · doi:10.1097/ppo.0b013e31827f123e · Cited by 31
Role of lymphocyte-specific protein tyrosine kinase (LCK) in the expansion of glioma-initiating cells by fractionated radiation
Kim, R.-K., Yoon, C., Hyun, K.-H., Lee, H., An, S., Park, M. J., Kim, M.-J., & Lee, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.072 · Cited by 32
Odin (ANKS1A) is a Src family kinase target in colorectal cancer cells
Emaduddin, M., Edelmann, M. J., Kessler, B. M., & Feller, S. M. (2008) · Cell Communication and Signaling · doi:10.1186/1478-811x-6-7 · Cited by 31
Cullin5 destabilizes Cas to inhibit Src-dependent cell transformation
Teckchandani, A. M., Laszlo, G. S., Simó, S., Shah, K. H., Pilling, C., Strait, A. A., & Cooper, J. A. (2013) · Journal of Cell Science · doi:10.1242/jcs.127829 · Cited by 30
1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway
Pang, X., Zhang, L., Lai, L., Chen, J., Wu, Y., Yi, Z., Zhang, J., Qu, W., Aggarwal, B. B., & Liu, M. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr052 · Cited by 31
c‐Src inhibitor selectively inhibits triple‐negative breast cancer overexpressed Vimentin in vitro and in vivo
Lou, L., Yu, Z., Wang, Y., Wang, S., & Zhao, Y. (2018) · Cancer Science · doi:10.1111/cas.13572 · Cited by 31
Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells
Borley, A., Hiscox, S., Gee, J. M. W., Smith, C. R., Shaw, V. E., Barrett-Lee, P. J., & Nicholson, R. I. (2008) · Breast Cancer Research · doi:10.1186/bcr2206 · Cited by 31
Synthesis and Src Kinase Inhibitory Activity of a Series of 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles
Boschelli, D. H., Wu, B., Ye, F., Wang, Y., Golas, J. M., Lucas, J., & Boschelli, F. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm061031t · Cited by 31
Quantification of Focal Adhesion Kinase Activation Loop Phosphorylation as a Biomarker of Src Activity
Ciccimaro, E., Hanks, S. K., & Blair, I. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052464 · Cited by 30
Src Family Tyrosine Kinases in Intestinal Homeostasis, Regeneration and Tumorigenesis
Sirvent, A., Mevizou, R., Naim, D., Lafitte, M., & Roche, S. (2020) · Cancers · doi:10.3390/cancers12082014 · Cited by 31
Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug Resistance
Rozengurt, E., & Eibl, G. (2021) · Cancers · doi:10.3390/cancers13205126 · Cited by 32
A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer
Pathak, H. B., Zhou, Y., Sethi, G., Hirst, J. J., Schilder, R. J., Golemis, E. A., & Godwin, A. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144126 · Cited by 30
Functionalized Caprolactone-Polyethylene Glycol Based Thermo-Responsive Hydrogels of Silibinin for the Treatment of Malignant Melanoma
Makhmalzadeh, B. S., Molavi, O., Vakili, M. R., Zhang, H., Solimani, A., Abyaneh, H. S., Löebenberg, R., Lai, R. L., & Lavasanifar, A. (2018) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps29726 · Cited by 31
c-Src/Histone Deacetylase 3 Interaction Is Crucial for Hepatocyte Growth Factor–Dependent Decrease of CXCR4 Expression in Highly Invasive Breast Tumor Cells
Matteucci, E., Ridolfi, E., Maroni, P., Bendinelli, P., & Desiderio, M. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0054 · Cited by 32
FRK plays an oncogenic role in non‐small cell lung cancer by enhancing the stemness phenotype via induction of metabolic reprogramming
Zhang, L., Yang, Y., Chai, L., Bu, H., Yang, Y., Huang, H., Ran, J., Zhu, Y., Li, L., Chen, F., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32530 · Cited by 29
BMP-7 Enhances Cell Migration and αvβ3 Integrin Expression via a c-Src-Dependent Pathway in Human Chondrosarcoma Cells
Chen, J., Yang, S.-T., Lin, C., Hsu, C., Tsai, C., Su, J.-L., & Tang, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112636 · Cited by 29
MPZL1 promotes tumor cell proliferation and migration via activation of Src kinase in ovarian cancer
Chen, D., Cao, L., & Wang, X. (2019) · Oncology Reports · doi:10.3892/or.2019.7199 · Cited by 29
Defining the “Metastasome”: Perspectives from the genome and molecular landscape in colorectal cancer for metastasis evolution and clinical consequences
Allgayer, H., Leupold, J. H., & Patil, N. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.018 · Cited by 29
Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signaling
Liu, A., Xie, H., Li, R., Ren, L., Yang, B., Dai, L., Lu, W., Liu, B., Ren, D., Zhang, X., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.05.008 · Cited by 27
Enhanced Effect of Connexin 43 on Cisplatin-Induced Cytotoxicity in Mesothelioma Cells
Sato, H., Iwata, H., Takano, Y., Yamada, R., Okuzawa, H., Nagashima, Y., Yamaura, K., Ueno, K., & Yano, T. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08327fp · Cited by 29
Prediction of lymph node metastasis and perineural invasion of biliary tract cancer by selected features from cDNA array data1
Murakawa, K., Tada, M., Takada, M., Tamoto, E., Shindoh, G., Teramoto, K., Matsunaga, A., Komuro, K., Kanai, M., Kawakami, A., et al. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.06.003 · Cited by 29
Constitutive activation of breast tumor kinase accelerates cell migration and tumor growth in vivo
Miah, S., Martin, A. P. J., & Lukong, K. E. (2012) · Oncogenesis · doi:10.1038/oncsis.2012.11 · Cited by 29
5-Deoxykaempferol Plays a Potential Therapeutic Role by Targeting Multiple Signaling Pathways in Skin Cancer
Lee, K., Lee, K. W., Byun, S., Jung, S. K., Seo, S. K., Heo, Y.-S., Bode, A. M., Lee, H. J., & Dong, Z. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0137 · Cited by 29
Discovery and preliminary structure–activity relationship studies of novel benzotriazine based compounds as Src inhibitors
Noronha, G., Barrett, K., Cao, J., Dneprovskaia, E., Fine, R., Gong, X., Gritzen, C., Hood, J. D., Kang, X., Klebansky, B., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.08.035 · Cited by 29
Apoptosis-Related (Survivin, Bcl-2), Tumor Suppressor Gene (p53), Proliferation (Ki-67), and Non-Receptor Tyrosine Kinase (Src) Markers Expression and Correlation With Clinicopathologic Variables in 60 Thymic Neoplasms
Khoury, T., Arshad, A., Bogner, P. N., Ramnath, N., Zhang, S., Chandrasekhar, R., Wilding, G. E., Alrawi, S., & Tan, D. (2009) · CHEST Journal · doi:10.1378/chest.08-2482 · Cited by 31
New pyrazolo‐[3,4‐ d ]‐pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells
Rossi, A., Schenone, S., Angelucci, A., Cozzi, M., Caracciolo, V., Pentimalli, F., Puca, A., Pucci, B., Montagna, R. L., Bologna, M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-148593 · Cited by 29
Cyr61 as mediator of Src signaling in triple negative breast cancer cells
Sánchez-Bailón, M. P., Calcabrini, A., Mayoral-Varo, V., Molinari, A., Wagner, K., Pérez‐Losada, J., Ciordia, S., Albar, J. P., & Martín-Pérez, J. (2015) · Oncotarget · doi:10.18632/oncotarget.3760 · Cited by 29

Authors: Summy, J. M., & Gallick, G. E.
Affiliations: The University of Texas MD Anderson Cancer Center (US)
Corresponding author: Gallick, Gary E.
Venue: Cancer and Metastasis Reviews
Publisher: Springer Science and Business Media LLC
Published: 2003-12
Volume: 22
Issue: 4
Pages: 337-358
ISSN: 0167-7659 (ISSN-L)
1573-7233
DOI: 10.1023/a:1023772912750
OpenAlex: W1589166971
Cited by: 827
References: 171
Citations by year: 2026: 15 · 2025: 15 · 2024: 17 · 2023: 17 · 2022: 26 · 2021: 27 · 2020: 26 · 2019: 35 · 2018: 32 · 2017: 28 · 2016: 32 · 2015: 37 · 2014: 64 · 2013: 55 · 2012: 49
FWCI: 4.32
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Cancer and Metastasis Reviews (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ca065527-07)
National Cancer Institute (U54CA090810, 2 R01 CA65527)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords: Src family kinases, Src kinase, non-receptor tyrosine kinase, tumor progression, metastasis, constitutive kinase activation, v-Src, malignant transformation, cell migration and invasion, angiogenesis, apoptosis resistance, cancer therapeutics, colorectal cancer, breast cancer, melanoma, lung cancer
MeSH terms: Enzyme Activation, Humans, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Signal Transduction, Disease Progression, src-Family Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Src family kinases in tumor progression and metastasis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks